Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab
Global pharmaceutical company, Sanofi will acquire a clinical-stage biopahrmaceutical company Kymab. Sanofi will acquire Kymab for an upfront payment of approximately $1.1... Read More
Glenmark introducing Remogliflozin + Vildagliptin combination first time in India
Glenmark Pharmaceuticals Limited is introducing a fixed dose combination (FDC) of Remogliflozin + Vildagliptin. Remogliflozin is Sodium Glucose Co-Transporter Inhibitor (SGLT2i). Sodium/glucose... Read More
Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx
Myovant Sciences is partnering with Pfizer to develop and commercialize Orgovyx for prostate cancer and women’s health. Orgovyx is the brand of... Read More
UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time
The UK today became the first country to approve the Covid-19 vaccine developed by Pfizer Inc and its German partner BioNTech SE.... Read More
Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development
Posted on28 Nov 2020
Comments0
More than 50 covid-19 vaccine candidate is currently under development. Here you can have the close look into the development status of... Read More
Pfizer submitted application for emergency use of Covid vaccine
US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government... Read More
Take Self Competency Test in Esxport Documentation
You can take a short and quick competency test on pharmaceutical export.
Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China
Posted on20 Nov 2020
Comments0
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Fresenius Kabi announced an agreement to develop, register and distribute Veltassa for the treatment... Read More
Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning
Posted on30 Oct 2020
Tagsgilead, Gilead Sciences, pharma strategic deal, Remdesivir, Strategic deal in pharma, strategic management in pharma, Veklury
Comments0
FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients 12 years of age... Read More
Pfizer’s Hospital Business acquires Arixa Pharma
Posted on24 Oct 2020
Comments0
Arixa Pharmaceuticals, a company developing next-generation oral antibiotics for drug-resistant Gram-negative infections announced that Pfizer’s Hospital Business has agreed to acquire Arixa.... Read More